Publications by authors named "Michael Fanucchi"

Claim this Profile
T
Thymoma-Associated Pleural Effusion Treated With Neoadjuvant Chemotherapy.
Sreshta Paranji, Aatif Khurshid, Pritika Sharma, Rathnamitreyee Vegunta, Michael Fanucchi

Cureus· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic syndromes in lung cancer and their management.
Asad Anwar, Firas Jafri, Sara Ashraf, Mohammad Ali S Jafri, Michael Fanucchi

Ann Transl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy.
Aaron D Brumbaugh, Roshni Narurkar, Kaushal Parikh, Michael Fanucchi, William H Frishman

Cardiol Rev· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer.
Kaushal Parikh, Arun Kumar, Jibran Ahmed, Asad Anwar, Carmelo Puccio, Michael Fanucchi

Cancer Immunol Immunother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors.
Jibran Ahmed, Arun Kumar, Kaushal Parikh, Asad Anwar, Bettina M Knoll, Michael Fanucchi

Oncoimmunology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability of and potential barriers preventing allogeneic stem cell transplant in sickle cell patients treated outside a sickle cell program.
Arun Kumar, Jibran Ahmed, Asad Anwar, Michael Fanucchi, Seah H Lim

Am J Hematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of bevacizumab in the management of the patient with malignant pleural effusion: more questions than answers.
Ralph Llewel Sabang, Deepthi Gandhiraj, Michael Fanucchi, Oleg Epelbaum

Expert Rev Respir Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxanes in the treatment of non-small cell lung cancer.
Michael Fanucchi, Fadlo R Khuri

Treat Respir Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.
John Kauh, Chantal Chanel-Vos, Daniel Escuin, Michael P Fanucchi, R Donald Harvey

Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances of novel targeted therapy in non-small cell lung cancer.
Jed A Katzel, Michael P Fanucchi, Zujun Li

J Hematol Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.
Jean-Yves Blay, Margaret von Mehren, Brian L Samuels, Michael P Fanucchi, Isabelle Ray-Coquard

Clin Cancer Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
Robert G Maki, J Kyle Wathen, Shreyaskumar R Patel, Dennis A Priebat, Scott H Okuno, Michael Fanucchi

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia in the setting of advanced gastrointestinal stromal tumor.
Jacfranz Guiteau, Michael Fanucchi, Andrew Folpe, Charles A Staley, David A Kooby

Am Surg· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
Michael P Fanucchi, Frank V Fossella, Robert Belt, Ronald Natale, Panos Fidias

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Michael Fanucchi, Fadlo R Khuri

Semin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the management of connective tissue malignancies.
Michael Fanucchi

Semin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan.
Sarah Richards, Jay N Umbreit, Michael P Fanucchi, Joan Giblin, Fadlo Khuri

South Med J· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis